RATIONALE: Pulmonologists frequently encounter indeterminate pulmonary nodules in practice, but it is unclear what clinical factors they rely on to guide the diagnostic evaluation. OBJECTIVES: To assess the current approach to the management of indeterminate pulmonary nodules and to determine the extent to which the addition of a hypothetical diagnostic blood test will influence clinical decision making. METHODS:Selected pulmonologists practicing in the United States were invited to participate in a conjoint exercise based on 20 randomly generated cases of varying age, smoking history, and nodule size. Some cases included the result of a hypothetical blood test. Each respondent chose from among three diagnostic options for a patient: noninvasive monitoring (i.e., serial CT or positron emission tomography scan), a minor procedure (i.e., biopsy or bronchoscopy), or a major procedure (i.e., video-assisted thorascopic surgery or thoracotomy). Multivariate logistic regression was used to assess the impact of the three risk factors and the diagnostic blood test on decision making. MEASUREMENTS AND MAIN RESULTS:Four hundred nineteen physicians participated (response rate, 10%). One hundred fifty-three physician surveys met predetermined criteria and were analyzed (4% of all invitees). A diagnostic procedure was recommended for 23% of 6-mm nodules, versus 54, 66, 77, and 84% of nodules 10, 14, 18, and 22 mm, respectively (P < 0.001). Older age limited recommendations for invasive testing: 54% of 80-year-olds versus 61, 64, 63, and 61% of patients 71, 62, 53, and 44 years of age, respectively (P < 0.001). In multivariate analyses, nodule size, smoking history, age, and the blood test each influenced decision making (P < 0.001). CONCLUSIONS: The pulmonologists who participated in this survey were more likely to proceed with invasive testing, instead of observation or additional imaging, as the size of the nodule increased. The use of a hypothetical blood test resulted in significant alterations in the decision to pursue invasive testing.
RCT Entities:
RATIONALE: Pulmonologists frequently encounter indeterminate pulmonary nodules in practice, but it is unclear what clinical factors they rely on to guide the diagnostic evaluation. OBJECTIVES: To assess the current approach to the management of indeterminate pulmonary nodules and to determine the extent to which the addition of a hypothetical diagnostic blood test will influence clinical decision making. METHODS: Selected pulmonologists practicing in the United States were invited to participate in a conjoint exercise based on 20 randomly generated cases of varying age, smoking history, and nodule size. Some cases included the result of a hypothetical blood test. Each respondent chose from among three diagnostic options for a patient: noninvasive monitoring (i.e., serial CT or positron emission tomography scan), a minor procedure (i.e., biopsy or bronchoscopy), or a major procedure (i.e., video-assisted thorascopic surgery or thoracotomy). Multivariate logistic regression was used to assess the impact of the three risk factors and the diagnostic blood test on decision making. MEASUREMENTS AND MAIN RESULTS: Four hundred nineteen physicians participated (response rate, 10%). One hundred fifty-three physician surveys met predetermined criteria and were analyzed (4% of all invitees). A diagnostic procedure was recommended for 23% of 6-mm nodules, versus 54, 66, 77, and 84% of nodules 10, 14, 18, and 22 mm, respectively (P < 0.001). Older age limited recommendations for invasive testing: 54% of 80-year-olds versus 61, 64, 63, and 61% of patients 71, 62, 53, and 44 years of age, respectively (P < 0.001). In multivariate analyses, nodule size, smoking history, age, and the blood test each influenced decision making (P < 0.001). CONCLUSIONS: The pulmonologists who participated in this survey were more likely to proceed with invasive testing, instead of observation or additional imaging, as the size of the nodule increased. The use of a hypothetical blood test resulted in significant alterations in the decision to pursue invasive testing.
Authors: Heber MacMahon; John H M Austin; Gordon Gamsu; Christian J Herold; James R Jett; David P Naidich; Edward F Patz; Stephen J Swensen Journal: Radiology Date: 2005-11 Impact factor: 11.105
Authors: Renda Soylemez Wiener; Michael K Gould; Steven Woloshin; Lisa M Schwartz; Jack A Clark Journal: Health Expect Date: 2012-12-16 Impact factor: 3.377
Authors: James M Isbell; Stephen Deppen; Joe B Putnam; Jonathan C Nesbitt; Eric S Lambright; Aaron Dawes; Pierre P Massion; Theodore Speroff; David R Jones; Eric L Grogan Journal: Ann Thorac Surg Date: 2011-01 Impact factor: 4.330
Authors: Christopher G Slatore; Nancy Press; David H Au; J Randall Curtis; Renda Soylemez Wiener; Linda Ganzini Journal: Ann Am Thorac Soc Date: 2013-08
Authors: Carolyn E Reed; David H Harpole; Katherine E Posther; Sandra L Woolson; Robert J Downey; Bryan F Meyers; Robert T Heelan; Homer A MacApinlac; Sin-Ho Jung; Gerard A Silvestri; Barry A Siegel; Valerie W Rusch Journal: J Thorac Cardiovasc Surg Date: 2003-12 Impact factor: 5.209
Authors: Christopher G Slatore; Nanda Horeweg; James R Jett; David E Midthun; Charles A Powell; Renda Soylemez Wiener; Juan P Wisnivesky; Michael K Gould Journal: Am J Respir Crit Care Med Date: 2015-08-15 Impact factor: 21.405
Authors: Neil N Trivedi; Mehrdad Arjomandi; James K Brown; Tess Rubenstein; Abigail D Rostykus; Stephanie Esposito; Eden Axler; Mike Beggs; Heng Yu; Luis Carbonell; Alice Juang; Sandy Kamer; Bhavin Patel; Shan Wang; Amanda L Fish; Zaid Haddad; Alan Hb Wu Journal: Biomed Res Clin Pract Date: 2018-10-29
Authors: Andrew V Kossenkov; Rehman Qureshi; Noor B Dawany; Jayamanna Wickramasinghe; Qin Liu; R Sonali Majumdar; Celia Chang; Sandy Widura; Trisha Kumar; Wen-Hwai Horng; Eric Konnisto; Gerard Criner; Jun-Chieh J Tsay; Harvey Pass; Sai Yendamuri; Anil Vachani; Thomas Bauer; Brian Nam; William N Rom; Michael K Showe; Louise C Showe Journal: Cancer Res Date: 2018-11-28 Impact factor: 12.701
Authors: Paul Kearney; Stephen W Hunsucker; Xiao-Jun Li; Alex Porter; Steven Springmeyer; Peter Mazzone Journal: PLoS One Date: 2017-05-17 Impact factor: 3.240
Authors: Gerard A Silvestri; Nichole T Tanner; Paul Kearney; Anil Vachani; Pierre P Massion; Alexander Porter; Steven C Springmeyer; Kenneth C Fang; David Midthun; Peter J Mazzone Journal: Chest Date: 2018-03-01 Impact factor: 9.410
Authors: Raymond U Osarogiagbon; Wei Liao; Nicholas R Faris; Meghan Meadows-Taylor; Carrie Fehnel; Jordan Lane; Sara C Williams; Anita A Patel; Olawale A Akinbobola; Alicia Pacheco; Amanda Epperson; Joy Luttrell; Denise McCoy; Laura McHugh; Raymond Signore; Anna M Bishop; Keith Tonkin; Robert Optican; Jeffrey Wright; Todd Robbins; Meredith A Ray; Matthew P Smeltzer Journal: J Clin Oncol Date: 2022-03-08 Impact factor: 50.717
Authors: J Scott Ferguson; Ryan Van Wert; Yoonha Choi; Michael J Rosenbluth; Kate Porta Smith; Jing Huang; Avrum Spira Journal: BMC Pulm Med Date: 2016-05-17 Impact factor: 3.317